Cargando…

The Impact of the Grid Size on TomoTherapy for Prostate Cancer

Discretization errors due to the digitization of computed tomography images and the calculation grid are a significant issue in radiation therapy. Such errors have been quantitatively reported for a fixed multifield intensity-modulated radiation therapy using traditional linear accelerators. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawashima, Motohiro, Kawamura, Hidemasa, Onishi, Masahiro, Takakusagi, Yosuke, Okonogi, Noriyuki, Okazaki, Atsushi, Sekihara, Tetsuo, Ando, Yoshitaka, Nakano, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618461/
https://www.ncbi.nlm.nih.gov/pubmed/28974860
http://dx.doi.org/10.4103/jmp.JMP_123_16
_version_ 1783267191283515392
author Kawashima, Motohiro
Kawamura, Hidemasa
Onishi, Masahiro
Takakusagi, Yosuke
Okonogi, Noriyuki
Okazaki, Atsushi
Sekihara, Tetsuo
Ando, Yoshitaka
Nakano, Takashi
author_facet Kawashima, Motohiro
Kawamura, Hidemasa
Onishi, Masahiro
Takakusagi, Yosuke
Okonogi, Noriyuki
Okazaki, Atsushi
Sekihara, Tetsuo
Ando, Yoshitaka
Nakano, Takashi
author_sort Kawashima, Motohiro
collection PubMed
description Discretization errors due to the digitization of computed tomography images and the calculation grid are a significant issue in radiation therapy. Such errors have been quantitatively reported for a fixed multifield intensity-modulated radiation therapy using traditional linear accelerators. The aim of this study is to quantify the influence of the calculation grid size on the dose distribution in TomoTherapy. This study used ten treatment plans for prostate cancer. The final dose calculation was performed with “fine” (2.73 mm) and “normal” (5.46 mm) grid sizes. The dose distributions were compared from different points of view: the dose-volume histogram (DVH) parameters for planning target volume (PTV) and organ at risk (OAR), the various indices, and dose differences. The DVH parameters were used Dmax, D2%, D2cc, Dmean, D95%, D98%, and Dmin for PTV and Dmax, D2%, and D2cc for OARs. The various indices used were homogeneity index and equivalent uniform dose for plan evaluation. Almost all of DVH parameters for the “fine” calculations tended to be higher than those for the “normal” calculations. The largest difference of DVH parameters for PTV was Dmax and that for OARs was rectal D2cc. The mean difference of Dmax was 3.5%, and the rectal D2cc was increased up to 6% at the maximum and 2.9% on average. The mean difference of D95% for PTV was the smallest among the differences of the other DVH parameters. For each index, whether there was a significant difference between the two grid sizes was determined through a paired t-test. There were significant differences for most of the indices. The dose difference between the “fine” and “normal” calculations was evaluated. Some points around high-dose regions had differences exceeding 5% of the prescription dose. The influence of the calculation grid size in TomoTherapy is smaller than traditional linear accelerators. However, there was a significant difference. We recommend calculating the final dose using the “fine” grid size.
format Online
Article
Text
id pubmed-5618461
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-56184612017-10-03 The Impact of the Grid Size on TomoTherapy for Prostate Cancer Kawashima, Motohiro Kawamura, Hidemasa Onishi, Masahiro Takakusagi, Yosuke Okonogi, Noriyuki Okazaki, Atsushi Sekihara, Tetsuo Ando, Yoshitaka Nakano, Takashi J Med Phys Technical Note Discretization errors due to the digitization of computed tomography images and the calculation grid are a significant issue in radiation therapy. Such errors have been quantitatively reported for a fixed multifield intensity-modulated radiation therapy using traditional linear accelerators. The aim of this study is to quantify the influence of the calculation grid size on the dose distribution in TomoTherapy. This study used ten treatment plans for prostate cancer. The final dose calculation was performed with “fine” (2.73 mm) and “normal” (5.46 mm) grid sizes. The dose distributions were compared from different points of view: the dose-volume histogram (DVH) parameters for planning target volume (PTV) and organ at risk (OAR), the various indices, and dose differences. The DVH parameters were used Dmax, D2%, D2cc, Dmean, D95%, D98%, and Dmin for PTV and Dmax, D2%, and D2cc for OARs. The various indices used were homogeneity index and equivalent uniform dose for plan evaluation. Almost all of DVH parameters for the “fine” calculations tended to be higher than those for the “normal” calculations. The largest difference of DVH parameters for PTV was Dmax and that for OARs was rectal D2cc. The mean difference of Dmax was 3.5%, and the rectal D2cc was increased up to 6% at the maximum and 2.9% on average. The mean difference of D95% for PTV was the smallest among the differences of the other DVH parameters. For each index, whether there was a significant difference between the two grid sizes was determined through a paired t-test. There were significant differences for most of the indices. The dose difference between the “fine” and “normal” calculations was evaluated. Some points around high-dose regions had differences exceeding 5% of the prescription dose. The influence of the calculation grid size in TomoTherapy is smaller than traditional linear accelerators. However, there was a significant difference. We recommend calculating the final dose using the “fine” grid size. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5618461/ /pubmed/28974860 http://dx.doi.org/10.4103/jmp.JMP_123_16 Text en Copyright: © 2017 Journal of Medical Physics http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Technical Note
Kawashima, Motohiro
Kawamura, Hidemasa
Onishi, Masahiro
Takakusagi, Yosuke
Okonogi, Noriyuki
Okazaki, Atsushi
Sekihara, Tetsuo
Ando, Yoshitaka
Nakano, Takashi
The Impact of the Grid Size on TomoTherapy for Prostate Cancer
title The Impact of the Grid Size on TomoTherapy for Prostate Cancer
title_full The Impact of the Grid Size on TomoTherapy for Prostate Cancer
title_fullStr The Impact of the Grid Size on TomoTherapy for Prostate Cancer
title_full_unstemmed The Impact of the Grid Size on TomoTherapy for Prostate Cancer
title_short The Impact of the Grid Size on TomoTherapy for Prostate Cancer
title_sort impact of the grid size on tomotherapy for prostate cancer
topic Technical Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618461/
https://www.ncbi.nlm.nih.gov/pubmed/28974860
http://dx.doi.org/10.4103/jmp.JMP_123_16
work_keys_str_mv AT kawashimamotohiro theimpactofthegridsizeontomotherapyforprostatecancer
AT kawamurahidemasa theimpactofthegridsizeontomotherapyforprostatecancer
AT onishimasahiro theimpactofthegridsizeontomotherapyforprostatecancer
AT takakusagiyosuke theimpactofthegridsizeontomotherapyforprostatecancer
AT okonoginoriyuki theimpactofthegridsizeontomotherapyforprostatecancer
AT okazakiatsushi theimpactofthegridsizeontomotherapyforprostatecancer
AT sekiharatetsuo theimpactofthegridsizeontomotherapyforprostatecancer
AT andoyoshitaka theimpactofthegridsizeontomotherapyforprostatecancer
AT nakanotakashi theimpactofthegridsizeontomotherapyforprostatecancer
AT kawashimamotohiro impactofthegridsizeontomotherapyforprostatecancer
AT kawamurahidemasa impactofthegridsizeontomotherapyforprostatecancer
AT onishimasahiro impactofthegridsizeontomotherapyforprostatecancer
AT takakusagiyosuke impactofthegridsizeontomotherapyforprostatecancer
AT okonoginoriyuki impactofthegridsizeontomotherapyforprostatecancer
AT okazakiatsushi impactofthegridsizeontomotherapyforprostatecancer
AT sekiharatetsuo impactofthegridsizeontomotherapyforprostatecancer
AT andoyoshitaka impactofthegridsizeontomotherapyforprostatecancer
AT nakanotakashi impactofthegridsizeontomotherapyforprostatecancer